{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T08:55:50Z","timestamp":1762505750180},"reference-count":74,"publisher":"Wiley","issue":"2","license":[{"start":{"date-parts":[[2011,3,10]],"date-time":"2011-03-10T00:00:00Z","timestamp":1299715200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Photoderm Photoimm Photomed"],"published-print":{"date-parts":[[2011,4]]},"abstract":"<jats:p><jats:bold>Background\/purpose: <\/jats:bold> Among the primary cutaneous T\u2010cell lymphomas, mycosis fungoides (MF) is the most common disease entity. Recently, an improved understanding of the pathology, clinical presentation, and prognosis of MF has lead to the development of new and practically useful classification and staging systems. In most patients, MF presents with patches and plaques and remains confined to the skin for years and decades, making it an ideal target for phototherapy. However, treatment schedules vary widely and this review describes the current knowledge about phototherapy of MF focusing mainly on narrow\u2010 and broadband UVB and 8\u2010methoxypsoralen plus UVA, its indications, practical aspects, and clinical outcome.<\/jats:p><jats:p><jats:bold>Methods: <\/jats:bold> Review and summary of the pertinent literature.<\/jats:p><jats:p><jats:bold>Results and conclusions: <\/jats:bold> Since 1976, when the first report on phototherapy for MF was published, sufficient evidence has accumulated to make narrowband UVB and PUVA safe and effective treatment options for early stages of the disease. In refractory cases or more advanced stages, combination of phototherapy with systemic treatments including mainly interferons and retinoids might be valuable. Additional research is required to further define the optimal treatment schedules and the role of maintenance.<\/jats:p>","DOI":"10.1111\/j.1600-0781.2011.00559.x","type":"journal-article","created":{"date-parts":[[2011,3,11]],"date-time":"2011-03-11T01:07:27Z","timestamp":1299805647000},"page":"68-74","source":"Crossref","is-referenced-by-count":36,"title":["Phototherapy of mycosis fungoides"],"prefix":"10.1111","volume":"27","author":[{"given":"Franz","family":"Trautinger","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2011,3,10]]},"reference":[{"key":"e_1_2_7_2_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2004-09-3502"},{"key":"e_1_2_7_3_2","first-page":"523","article-title":"The 2008 WHO classification of lymphomas","author":"Jaffe ES.","year":"2009","journal-title":"implications for clinical practice and translational research"},{"key":"e_1_2_7_4_2","first-page":"5064","article-title":"Cutaneous lymphoma incidence patterns in the United States","volume":"113","author":"Bradford PT","year":"2009","journal-title":"a population-based study of 3884 cases"},{"key":"e_1_2_7_5_2","doi-asserted-by":"publisher","DOI":"10.1001\/archderm.143.7.854"},{"key":"e_1_2_7_6_2","first-page":"4730","article-title":"Survival outcomes and prognostic factors in mycosis fungoides\/Sezary syndrome","volume":"28","author":"Agar NS","year":"2010","journal-title":"validation of the revised international society for cutaneous lymphomas\/European organisation for research and treatment of cancer staging proposal"},{"key":"e_1_2_7_7_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra032810"},{"key":"e_1_2_7_8_2","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-121-8-199410150-00007"},{"key":"e_1_2_7_9_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejca.2006.01.025"},{"key":"e_1_2_7_10_2","first-page":"725","article-title":"Report of the committee on staging and classification of cutaneous T\u2010cell lymphomas","volume":"63","author":"Bunn PA","year":"1979","journal-title":"Cancer Treat Rep"},{"key":"e_1_2_7_11_2","first-page":"1713","article-title":"Revisions to the staging and classification of mycosis fungoides and Sezary syndrome","volume":"110","author":"Olsen E","year":"2007","journal-title":"a proposal of the International Society for Cutaneous Lymphomas (ISCL) and the Cutaneous Lymphoma Task Force of the European Organization of Research and Treatment of Cancer (EORTC)"},{"key":"e_1_2_7_12_2","first-page":"iv115","article-title":"Primary cutaneous lymphoma","volume":"20","author":"Willemze R","year":"2009","journal-title":"ESMO clinical recommendations for diagnosis, treatment and follow-up"},{"key":"e_1_2_7_13_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.2003.05698.x"},{"key":"e_1_2_7_14_2","doi-asserted-by":"publisher","DOI":"10.1172\/JCI24826"},{"key":"e_1_2_7_15_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM198912283212603"},{"key":"e_1_2_7_16_2","first-page":"144","article-title":"Personal sun exposure and risk of non Hodgkin lymphoma","volume":"122","author":"Kricker A","year":"2008","journal-title":"a pooled analysis from the Interlymph Consortium"},{"key":"e_1_2_7_17_2","first-page":"1569","article-title":"Pigmentary characteristics, UV radiation exposure, and risk of non\u2010Hodgkin lymphoma","volume":"19","author":"Veierod MB","year":"2010","journal-title":"a prospective study among Scandinavian women"},{"key":"e_1_2_7_18_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1523-1747.1999.00507.x"},{"key":"e_1_2_7_19_2","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(197608)38:2<683::AID-CNCR2820380210>3.0.CO;2-V"},{"key":"e_1_2_7_20_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM198702053160603"},{"key":"e_1_2_7_21_2","first-page":"652","article-title":"Extracorporeal photopheresis","volume":"61","author":"Knobler R","year":"2009","journal-title":"past, present, and future"},{"key":"e_1_2_7_22_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1396-0296.2003.01646.x"},{"key":"e_1_2_7_23_2","doi-asserted-by":"publisher","DOI":"10.1159\/000241302"},{"key":"e_1_2_7_24_2","doi-asserted-by":"publisher","DOI":"10.1159\/000226135"},{"key":"e_1_2_7_25_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1468-3083.2007.02554.x"},{"key":"e_1_2_7_26_2","doi-asserted-by":"crossref","first-page":"288","DOI":"10.2340\/00015555-0409","article-title":"Long\u2010term follow\u2010up of photodynamic therapy for mycosis fungoides","volume":"88","author":"Edstrom DW","year":"2008","journal-title":"Acta Derm Venereol"},{"key":"e_1_2_7_27_2","first-page":"410","article-title":"Topical 5\u2010aminolevulinic acid photodynamic therapy for the treatment of unilesional mycosis fungoides","volume":"47","author":"Recio ED","year":"2008","journal-title":"a report of two cases and review of the literature"},{"key":"e_1_2_7_28_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1525-1470.2005.22119.x"},{"key":"e_1_2_7_29_2","first-page":"217","article-title":"Efficacy of ultraviolet A1 phototherapy on the expression of bcl\u20102 in atopic dermatitis and cutaneous T\u2010cell lymphoma in vivo","volume":"18","author":"Breuckmann F","year":"2002","journal-title":"a comparison study"},{"key":"e_1_2_7_30_2","doi-asserted-by":"publisher","DOI":"10.1001\/archderm.140.10.1291"},{"key":"e_1_2_7_31_2","first-page":"39","article-title":"Phototherapy for cutaneous T\u2010cell lymphoma","volume":"60","author":"Carter J","year":"2009","journal-title":"online survey and literature review"},{"key":"e_1_2_7_32_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0889-8588(18)30059-5"},{"key":"e_1_2_7_33_2","doi-asserted-by":"publisher","DOI":"10.1007\/978-3-540-36693-5_6"},{"key":"e_1_2_7_34_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0190-9622(84)70030-2"},{"key":"e_1_2_7_35_2","doi-asserted-by":"publisher","DOI":"10.1001\/archderm.141.3.305"},{"key":"e_1_2_7_36_2","first-page":"364","article-title":"Total skin electron radiation in the management of mycosis fungoides","volume":"47","author":"Jones GW","year":"2002","journal-title":"consensus of the EORTC-cutaneous lymphoma project group"},{"key":"e_1_2_7_37_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0360-3016(98)00517-3"},{"key":"e_1_2_7_38_2","doi-asserted-by":"publisher","DOI":"10.1001\/archderm.139.2.165"},{"key":"e_1_2_7_39_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1439-0353.2003.03615.x"},{"key":"e_1_2_7_40_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.1994.tb02910.x"},{"key":"e_1_2_7_41_2","doi-asserted-by":"publisher","DOI":"10.1080\/00015550510032814"},{"key":"e_1_2_7_42_2","doi-asserted-by":"publisher","DOI":"10.1001\/archderm.134.5.595"},{"key":"e_1_2_7_43_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0781.1999.tb00052.x"},{"key":"e_1_2_7_44_2","doi-asserted-by":"publisher","DOI":"10.1001\/archderm.134.12.1582"},{"key":"e_1_2_7_45_2","first-page":"337","article-title":"Alpha recombinant interferon in the treatment of mycosis fungoides (MF)","volume":"72","author":"Tura S","year":"1987","journal-title":"Haematologica"},{"key":"e_1_2_7_46_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0190-9622(89)70049-9"},{"key":"e_1_2_7_47_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1529-8019.2006.00083.x"},{"key":"e_1_2_7_48_2","first-page":"S7","article-title":"Therapeutic advances in cutaneous T\u2010cell lymphoma (CTCL)","volume":"33","author":"Stadler R","year":"2006","journal-title":"from retinoids to rexinoids"},{"key":"e_1_2_7_49_2","doi-asserted-by":"publisher","DOI":"10.3816\/CLM.2000.s.008"},{"key":"e_1_2_7_50_2","first-page":"29","article-title":"Optimal combination with PUVA","volume":"21","author":"Stadler R.","year":"2007","journal-title":"rationale and clinical trial update"},{"key":"e_1_2_7_51_2","first-page":"2456","article-title":"Bexarotene is effective and safe for treatment of refractory advanced\u2010stage cutaneous T\u2010cell lymphoma","volume":"19","author":"Duvic M","year":"2001","journal-title":"multinational phase II\u2013III trial results"},{"key":"e_1_2_7_52_2","doi-asserted-by":"publisher","DOI":"10.2165\/00128071-200809030-00005"},{"key":"e_1_2_7_53_2","first-page":"134","article-title":"Treatment of mycosis fungoides with oral bexarotene combined with PUVA","volume":"1","author":"Stern DK","year":"2002","journal-title":"J Drugs Dermatol"},{"key":"e_1_2_7_54_2","first-page":"570","article-title":"Cutaneous T\u2010cell lymphoma treatment using bexarotene and PUVA","volume":"51","author":"Singh F","year":"2004","journal-title":"a case series"},{"key":"e_1_2_7_55_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-4632.2007.03147.x"},{"key":"e_1_2_7_56_2","doi-asserted-by":"publisher","DOI":"10.1159\/000078595"},{"key":"e_1_2_7_57_2","first-page":"771","article-title":"Psoralen plus long\u2010wave UV\u2010A (PUVA) and bexarotene therapy","volume":"139","author":"McGinnis KS","year":"2003","journal-title":"an effective and synergistic combined adjunct to therapy for patients with advanced cutaneous T-cell lymphoma"},{"key":"e_1_2_7_58_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.2005.06616.x"},{"issue":"1","key":"e_1_2_7_59_2","first-page":"33","article-title":"Bexarotene plus PUVA plus radiation combination therapy for mycosis fungoides","volume":"26","author":"Coors E.","year":"2008","journal-title":"Dermatol Clin"},{"key":"e_1_2_7_60_2","first-page":"3578","article-title":"Prospective randomized multicenter clinical trial on the use of interferon \u03b1\u20102a plus acitretin versus interferon \u03b1\u20102a plus PUVA in patients with cutaneous T\u2010cell lymphoma stages I and II","volume":"92","author":"Stadler R","year":"1998","journal-title":"Blood"},{"key":"e_1_2_7_61_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0190-9622(86)70128-X"},{"key":"e_1_2_7_62_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(79)91223-6"},{"key":"e_1_2_7_63_2","first-page":"355","article-title":"Home ultraviolet phototherapy of early mycosis fungoides","volume":"6","author":"Milstein HI","year":"1982","journal-title":"preliminary observations"},{"key":"e_1_2_7_64_2","first-page":"73","article-title":"Home UV phototherapy of early mycosis fungoides","volume":"29","author":"Resnik KS","year":"1993","journal-title":"long-term follow-up observations in thirty-one patients"},{"key":"e_1_2_7_65_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.1988.tb07096.x"},{"key":"e_1_2_7_66_2","doi-asserted-by":"publisher","DOI":"10.1111\/1523-1747.ep12520022"},{"key":"e_1_2_7_67_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0190-9622(99)70008-3"},{"key":"e_1_2_7_68_2","doi-asserted-by":"publisher","DOI":"10.1001\/archderm.135.11.1377"},{"key":"e_1_2_7_69_2","first-page":"215","article-title":"Narrowband UVB and psoralen\u2010UVA in the treatment of early\u2010stage mycosis fungoides","volume":"48","author":"Diederen PVMM","year":"2003","journal-title":"a retrospective study"},{"key":"e_1_2_7_70_2","first-page":"413","article-title":"Narrowband UVB and PUVA in the treatment of mycosis fungoides","volume":"87","author":"Ahmad K","year":"2007","journal-title":"a retrospective study"},{"key":"e_1_2_7_71_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.2004.06128.x"},{"key":"e_1_2_7_72_2","first-page":"2321","article-title":"Maintenance therapy in cutaneous T\u2010cell lymphoma","volume":"43","author":"Dummer R","year":"2007","journal-title":"who, when, what?"},{"key":"e_1_2_7_73_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jdermsci.2007.09.001"},{"key":"e_1_2_7_74_2","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(19800101)45:1<137::AID-CNCR2820450124>3.0.CO;2-K"},{"key":"e_1_2_7_75_2","first-page":"1098","article-title":"Histologic assessment of lymph nodes in mycosis fungoides\/Sezary syndrome (cutaneous T\u2010cell lymphoma)","volume":"16","author":"Sausville EA","year":"1985","journal-title":"clinical correlations and prognostic import of a new classification system"}],"container-title":["Photodermatology, Photoimmunology &amp; Photomedicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1600-0781.2011.00559.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1600-0781.2011.00559.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,31]],"date-time":"2023-10-31T12:59:04Z","timestamp":1698757144000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1600-0781.2011.00559.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,3,10]]},"references-count":74,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2011,4]]}},"alternative-id":["10.1111\/j.1600-0781.2011.00559.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1600-0781.2011.00559.x","archive":["Portico"],"relation":{},"ISSN":["0905-4383","1600-0781"],"issn-type":[{"value":"0905-4383","type":"print"},{"value":"1600-0781","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,3,10]]}}}